Dr. Howard Walpole, of the Okyanos Heart Institute, is delivering two free educational seminars on the use of adult stem cells from a person’s own body fat to treat chronic coronary artery disease (CAD) in Boca Raton on June 27th and 28th at the Boca Raton Marriott, 5150 Town Center Circle, Boca Raton, FL 33486. To register for this FREE educational seminar call toll free 1-855-659-6790 or visit Okyanos.com/seminars as seating is limited. Dr. Walpole is the Chief Medical Officer of Okyanos (www.okyanos.com), which brings a new standard of care and better quality of life to patients with chronic CAD using these cells.
Walpole, a Trustee of the American College of Cardiology (ACC) has completed approximately 17,000 procedures in his 25 years of practice as an interventional cardiologist. “Innovative research into the use of adult stem cells for cardiovascular disease has led to promising advances in cardiac care, particularly for patients where additional stents or bypass surgery are no longer a viable option..” he explained. “I am very pleased to educate patients on the potential of combining cardiac cell therapy with medical best practices done in a cardiac cell therapy center of excellence.”
Okyanos Heart Institute is located on Grand Bahama Island, a 20-minute flight from Fort Lauderdale. Okyanos uses an EU-approved device to safely separate adult stem cells from body fat. These stem cells can then be delivered in the heart where they have been shown to improve heart function and repair damaged heart tissue as a result of a heart attack per a rigorous clinical trial called PRECISE.
Dr. Walpole further stated, “After a 25 year career of successfully treating patients with cardiovascular disease I found that conventional therapies, as workable as they are, have limits. My research into the use of a person’s own adult stem cells has led me to believe that many patients with chronic coronary artery disease who have hit those limits can benefit from cardiac cell therapy now.”
Cardiac cell therapy trials for congestive heart failure, angina and CAD have been done at leading research institutions such as University of Miami, Mayo Clinic and Cleveland Clinic and have shown to be effective when using stem cells, such as fat derived cells, which grow new blood vessels in the heart a process known as angiogenesis. Okyanos Founder and CEO, Matthew Feshbach, says, “We founded Okyanos Heart Institute to help those patients who can benefit from cardiac cell therapy. Okyanos is completely focused on providing a new standard of care to patients so they can have a better quality of life. This will benefit not only the patient but their family and society.”